• The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non-Small Cell Lung Cancer | PTCE Pharmacy Connect

  • Oct 30 2024
  • Length: 36 mins
  • Podcast

The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non-Small Cell Lung Cancer | PTCE Pharmacy Connect

Listen for free

View show details

  • Summary

  • Educational Objectives

    • Review recent clinical updates of RET inhibitors and how they fit into the treatment paradigm for non‒small cell lung cancer
    • Identify and manage adverse effects of RET inhibitors to ensure patient safety and improve adherence

    Faculty

    Lauren Ledbetter, PharmD, BCOP

    Clinical Pharmacy Specialist, Thoracic Medical Oncology

    The James Cancer Hospital at The Ohio State University

    Columbus, Ohio

    Moderator

    Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

    Clinical Pharmacy Manager

    University of Kansas Cancer Center

    Division of Hematologic Malignancies & Cellular Therapeutics

    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.5 CEU) under the ACPE universal activity number 0290-0000-24-304-H01-P. The activity is available for CE credit through October 31, 2025.

    This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non-Small Cell Lung Cancer | PTCE Pharmacy Connect

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available